Organised by MediMix and sponsored by Amgen and Alfasigma
Thursday 19 March 2026
19:00 – 22:00
NEW FORMAT
A panel of Belgian rheumatologists will distill and discuss the key 2025 highlights from major international congresses and recent publications.
In addition, an experienced endocrinologist will shed light on co-morbidities and medication related side effects frequently encountered in rheumatology practice—bridging specialties to support optimal patient care.
Guided by a scientific moderator, the session will translate the latest evidence into practical, clinically relevant insights.
We kindly invite you to join the discussion!
You can attend a live meeting at one of the hubs or follow the meeting online.
